CStone Pharma Grants Jiangsu Hengrui Rights to Investigational Cancer Drug in Greater China
CStone Pharma Grants Jiangsu Hengrui Rights to Investigational Cancer Drug in Greater China
中石制药授予江苏恒瑞在大中华区研究抗癌药物的权利
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册